بسم هللا الرحمن الرحيم. Prof soha Talaat

Similar documents
Terminology Estimate the risk of malignancy in adnexal masses - Overview

JMSCR Vol 05 Issue 06 Page June 2017

The Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD

Researcher 2018;10(8)

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

Adnexal Masses and Problem Solving Pelvic MRI

Diagnostic accuracy of ultrasonography with color doppler imaging techniques in adnexal masses and correlation with histopathological analysis

Ovarian Lesion Benign vs Malignant?

Assessment of adnexal masses. Ultrasound workup of adnexal masses. symptoms. symptoms. Age. Serum tumor markers 10/1/2018

IOTA and Models for Screening for Ovarian Cancer

2/24/19. Ovarian pathology: IOTA ADNEXAL MASSES. Content. IOTA terms for description of an adnexal mass. IOTA terms for description of an adnexal mass

Triage of Ovarian Masses. Andreas Obermair Brisbane

Top Tips for Gynaecological Ultrasound. Catherine Kirkpatrick Consultant Sonographer Dublin Oct 2018

A Practical Approach to Adnexal Masses

MR diagnostics of adnexal masses

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

Gynecologic Ultrasound. Sujata Ghate, MD Associate Professor of Radiology Duke University Medical Center

MRI features of primary and metastatic mucinous ovarian tumors

Risk of Malignancy Index in the Preoperative Evaluation of Patients with Adnexal Masses among Women of Perimenopausal and Postmenopausal Age Group

Can diffusion weighted imaging distinguish between benign and malignant solid or predominantly solid gynecological adnexal masses?

Characterizing Adnexal Masses: Pearls and Pitfalls 20 th Annual Summer Practicum SCBT-MR Jackson Hole August 11, 2010

Adnexal Masses in Menopausal Women Surgery or Surveillance?

Imaging evaluation of ovarian masses.

MR Imaging of the Adnexal Masses: A Review

Case 9551 Primary ovarian Burkitt lymphoma

ISUOG Basic Training Typical Ultrasound Appearances of Common Pathologies in the Adnexae

Value of MRI in Characterizing Adnexal Masses

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

H&E, IHC anti- Cytokeratin

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

Role of Diffusion weighted MR Imaging in the Evaluation of Ovarian Tumors

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

Clinical summary. Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT.

CAN TV U/S REDUCE THE

MR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI

3 cell types in the normal ovary

Histopathological analysis of neoplastic and non neoplastic lesions of ovary: A study of one hundred cases

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

3 cell types in the normal ovary

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

American Journal of Oral Medicine and Radiology

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

OVARIES. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L13 Dr: Ali Eltayb.


EDUCATIONAL COMMENTARY CA 125. Learning Outcomes

One of the commonest gynecological cancers,especially in white Americans.

Staging and Treatment Update for Gynecologic Malignancies

Institute of Pathology First Faculty of Medicine Charles University. Ovary

Serous borderline tumor icd 10

Category Term Definition Comments 1 Major Categories 1a

Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh

General history. Basic Data : Age :62y/o Date of admitted: Married status : Married

See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.

Role of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective

Diane DeFriend Derriford Hospital, Plymouth

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

IN THE NAME OF GOD POV: CYSTIC OVARIAN LESION

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

FDG-PET/CT in Gynaecologic Cancers

Approach to imaging of the ovaries

Low-grade serous neoplasia. Robert A. Soslow, MD

Endometrioma With Calcification Simulating a Dermoid on Sonography

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management

What Radiologists do?

Case Fibrothecoma of the ovary

Clinicopathological and Histological Features of Ovarian Tumour- A Study

A NEW QUANTITATIVE METHOD TO EVALUATE ADNEXAL TUMORS

Borderline Ovarian Tumours:MRI features to aid a challenging diagnosis

Staging Colorectal Cancer

Current staging of endometrial carcinoma with MR imaging

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

Index. mri.theclinics.com. Note: Page numbers of article titles are in boldface type.

Ovarian pathology: A practical approach to imaging diagnosis and management

Cervical Cancer: 2018 FIGO Staging

Pathology of the female genital tract

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Evaluation of serum level of CA-125 and HE4 in patients with an adnexal mass for the discrimination of benign from malignant cases

Malignant Transformation of Endometriosis: Magnetic Resonance Imaging Aspects

Malignant Transformation of Endometriosis: Magnetic Resonance Imaging Aspects

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Utility of ADC Measurements in the Discrimination between Benign and Lymphomatous Abdomino-Pelvic Lymph Nodes

The relative frequency and histopathological patterns of ovarian lesions: study of 116 cases

PET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp

Ubol Saeng-Anan, Tawiwan Pantasri, Vithida Neeyalavira, Theera Tongsong*

The new FIGO classification in endometrial carcinoma

Adnexal Masses in Menopausal Women

JMSCR Vol 3 Issue 9 Page September 2015

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

GENERAL DATA. Sex : female Age : 40 years old Marriage status : married

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

3 Summary of clinical applications and limitations of measurements

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens

Neoplasia literally means "new growth.

Imaging in gastric cancer

The key contribution of MRI in adnexal mass evaluation is in: 1. Identifying benign features. 2. Identifying malignant features.

Is It Time To Implement Ovarian Cancer Screening?

Transcription:

بسم هللا الرحمن الرحيم

Ovarian tumors The leading indication for gynecologic surgery. Preoperative characterization of complex solid and cystic adnexal masses is crucial for informing patients about possible surgical strategies.

Ovarian cancer It is a leading cause of death among women It is the second most common gynecological cancer after cancer cervix It is the fifth most common cancer in women after (lung, breast, colorectal, and pancreatic cancers)

Ovarian cancer Approximately 75% 80% of ovarian cancers are diagnosed at stages II IV. Patients with stage IA or IB disease have a 90% 95% 5-year survival rate following surgery alone whereas patients with stage IV disease have a dismal prognosis, with a 10% 5-year survival rate despite aggressive multimodality treatment.

Borderline ovarian tumors Comprise up to 15 20% of ovarian epithelial neoplasms. Borderline ovarian tumors are histologically characterized as epithelial tumors with a stratified growth pattern but without destructive stromal invasion. Serous and mucinous neoplasms constitute the majority of borderline tumors and occur mostly in women of reproductive age Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol2005 ; 123[suppl]:S13 S57

Proper management depends on: Clinical examination OECs are notoriously difficult to diagnose in the early stages. Even patients with advanced disease may present with nonspecific abdomino-pelvic symptoms. Laboratory tests Although CA 125 is a useful biomarker, elevated CA-125 levels are seen in only 50% 60% of mucinous or clear cell variants and early-stage cancers. Radiological assessment

Pelvic & TVS with CFM The initial diagnostic modality of choice.

TVS Colour Doppler & 3D Combining morphologic assessment with TVS with color Doppler features has allowed accurate assessments, the overall vascularity was classified as high, low, or intermediate, rather than determining vascular indices. Improves the detection of morphologic abnormalities indicative of neoplastic ovarian masses. In particular, small papillary projections or focal wall (mural) irregularities.

Role of Cross-sectional Imaging Diagnosis, Characterization, and Surveillance Assessment of primary tumours. The pattern of extra-ovarian spread may be (a) extraovarian intrapelvic (stage II). (b) extrapelvic intraabdominal (stage III). (c) Intra-abdominal with intrahepatic parenchymal deposits or extra-abdominal with distant metastasis (stage IV).

The emerging role of functional imaging techniques Radioimmunoscintigraphy, PET/CT, diffusionweighted MRI, dynamic contrast-enhanced MRI, and magnetic resonance spectroscopy in staging ovarian cancer and assessing treatment response. Diffusion MRI The combination of functional information with conventional anatomical visualization holds promise to accurately characterize peritoneal disease, and provides noninvasive biomarkers of therapeutic performance and patient prognosis.

Conventional MRI : Contrast-enhanced MRI may be helpful in cases of complex ultrasound findings MR Imaging protocol: Sagittal T2 Axial T2 Axial T1 Axial T1 SPAIR DWI (b: 0, 500, 1000, and 1500) Coronal T2 Axial T1 post contrast Coronal T1 post contrast

Interpretation of images: A)Conventional images Appearance of the tumor ; whether cystic, solid or mixed. Involvement of one or both ovaries Signal intensity Enhancement Wall thickness Presence of vegetations Ascites Lymph nodes Other pelvic organs Peritoneal and omental deposit

One of the new functional MRI techniques is DWI Tissue microstructures affect the random motion of water molecules

Tissues with low cellularity free water diffusion (Low signal) Tissues with high cellularity restriction of water diffusion (high signal)

B) DWI Qualitatively, regarding the signal Restricted diffusion = DW+ ADC Quantitatively, regarding the ADC values ADC maps generated from different b values ROI measured manually, over the largest possible area for the solid and cystic tumors ADC value 1.25 x 10-3 mm2/s may be an optimal cutoff value (Li et al, 2011)

What are the different clinical applications? Characterization of primary lesion

Peritoneal deposits

Lymph node assessment

Differentiating residual and Recurrent Disease from Post operative Change

A study was performed on ovarian tumors (Soha Talaat,Safaa saif, sahar mansour,2011) ADC for cystic component Minimum Maximum Mean +/-SD p-value ADC ( x 10-3 ) in malignant tumors 1.59 2.37 2.0375 (± 0.37) 0.911 ADC ( x 10-3 )in benign tumors 1.2 2.73 2.0027 (± 0.56)

ADC for solid component Minimum Maximum Mean +/-SD p-value ADC ( x 10-3 ) in malignant tumors 0.47 0.75 0.6033 (± 0.11) 0.058 ADC ( x 10-3 )in benign tumors 0.39 2.3 1.2014 (± 0.67)

100% 90% 80% 100% 83.30% 85.70% 85% 80% 78.60% 70% 60% 50% 40% MRI DW 30% 20% 10% 0% SENSITIVITY SPECIFICITY ACCURACY

case 1 Female patient 21 year old complaining of abdominal enlargement.us showed solid pelvi-abdominal mass with increased vascularity on Doppler examination

Case 1

case 1 Pathological diagnosis Granulosa cell tumor DWI High signal on DWI Low signal on ADC maps ADC value 0.68 x 10-3mm2/s

case 2 47 year old female patient came complaining of abdominal pain, US showed multilocular adnexal mass

Case 2 Conventional MRI Benign looking, likely serous cystadenoma Minimal free pelvic ascites

Case 2 DWI High Signal On DWI(T2 shine through) High signal on ADC maps ADC value 2.01 x 10-3mm2/s Pathological diagnosis Serous cystadenoma

case 3 Female patient 35 year old complained of abdominal pain, TVUS showed a deeply seated rounded right solid ovarian mass, Marked vascularity on Doppler examination

case 4

case 4 No abnormal high signal on DWI High signal on ADC map ADC value 0.98 x 10-3mm2/s Pathological diagnosis Ovarian Fibroma

case 4 Female patient 34 year old complaining of abdominal discomfort, US revealed complex adnexal mass with multiple papillary projections

case 5

case 4 DWI Papillary projections moderate high signal Low signal on ADC maps ADC values 1.03 x 10-3mm2/s Pathological diagnosis Borderline papillary serous cystadenoma

case 5 Female patient 42 year old came complaining of dull aching pelvic pain,us revealed two masses(pelvic and left lumbar) with echogenic foci

6 case

case 6

case 5 DWI Nodular part showed foci of restricted diffusion Marked low ADC values for both masses (0.39 x 10-3 mm2/s) and(0.64 x 10-3 mm2/s) Pathological diagnosis Bilateral mature cystic teratomas Mature cystic teratomas showed restriction may be attributed to keratinoid substance and Rokitansky protuberance

case 6 Pregnant Female 25 year old came complaining of dull aching right hypochondrial pain

case 7 Female patient, 40 years old, pregnant (32 wks),complaining of severe diffuse pelvi-abdominal pain and intermittent attacks of vaginal bleeding

Cervical& upper vaginalmass Mass Diffusion ADC

Limitations DWI interpretation should be in conjunction with other morphological criteria in conventional MRI sequences Recommendations Study with large number of cases with special concern for BOTs Cases of mature cystic teratomas better to be excluded as their DWI findings are misleading and can give false results

DWI is one of the new functional MRI techniques When properly indicated, it can help increasing the specificity of MRI DWI implies using: Completely noninvasive technique No radiation exposure Might be an alternative for contrast (pregnancy) Increases the radiologist s confidence in image interpretation DWI interpretation should be done in conjugation with the conventional MRI

Ovarian lesions detected by US Functional anechoic cyst less than or equal 5 cm Complex cystic (with no solid parts) Complex cystic and solid Purely solid repeated follow up by US MRI for characterization (T1, T2, fat suppression) MRI for staging (T1, T2, fat suppression, post contrast, DWI ) MRI for staging (T1, T2, fat suppression, post contrast, DWI ) complicat ed or increased in size low signal in T2, and DWI in favor of benignity High signal in T2, and DWI in favor of malignanc y MRI